The Vanguard Group Discloses Position in Life Science REIT

The Vanguard Group, Inc. has issued a Form 8.3 disclosure regarding its position in Life Science REIT plc. This form is mandatory under Rule 8.3 of the Takeover Code, requiring entities with a 1% or more interest in relevant securities to declare their positions. As of April 8, 2025, Vanguard holds 3,514,183 ordinary shares, equivalent to 1% of Life Science REIT's securities.

The form details no other significant dealings or derivative positions additional to this equity interest. Notably, no indemnity, options, or other arrangements influence Vanguard's dealings beyond this disclosure. It's a standard procedural step reflecting compliance with the regulatory framework, particularly during takeover activities.